Skip to main content

Table 5 GLM model for 12-week self-reported quit; adjusted odds ratios with 95 % confidence intervals (CI) and significance results

From: Gender difference and effect of pharmacotherapy: findings from a smoking cessation service

Variable

Level

Quit rate – n/N (%)

Odds ratio (95 % CI)

Wald (d.f.)

p-value

Sex

   

8.9 (1)

0.003

Male

905/3055 (29.6 %)

1

  

Female

996/3904 (25.5 %)

0.84 (0.76–0.94)

 

0.003

Region

   

334.3 (3)

<0.001

East Sussex

702/3773 (18.6 %)

1

  

Sandwell

913/2331 (39.2 %)

3.28 (2.89–3.73)

 

<0.001

Walsall

37/140 (26.4 %)

1.50 (1.01–2.22)

 

0.04

Worcestershire

249/715 (34.8 %)

2.29 (1.89–2.77)

 

<0.001

Age

   

82.7 (4)

<0.001

12–19

89/426 (20.9 %)

1

  

20–29

211/2041 (20.3 %)

1.47 (1.08–2.01)

 

0.015

30–49

829/2963 (28.0 %)

2.23 (1.68–2.95)

 

<0.001

50–69

661/2158 (30.6 %)

2.72 (2.04–3.63)

 

<0.001

70+

111/371 (29.9 %)

3.18 (2.22–4.56)

 

<0.001

Counselling

   

11.8 (6)

0.07

One-to-one

1479/5666 (26.1 %)

1

  

Drop-in

130/350 (37.1 %)

1.43 (1.09–1.87)

 

0.01

GP

125/326 (38.3 %)

1.05 (0.81–1.36)

 

0.7

Pharmacy

68/207 (32.9 %)

1.17 (0.86–1.59)

 

0.3

Nurse

35/165 (21.2 %)

0.80 (0.54–1.19)

 

0.3

Telephone

53/185 (28.6 %)

1.13 (0.81–1.59)

 

0.5

Other

11/57 (19.3 %)

0.57 (0.28–1.17)

 

0.1

Treatment

   

175.8 (1)

<0.001

NRT

1513/6085 (24.9 %)

1

  

Varenicline

388/874 (44.4 %)

2.87 (2.46–3.35)

 

<0.001